Peptide Profile
Thymosin Alpha-1 (Thymalfasin)
Thymosin Alpha-1, known pharmaceutically as **Thymalfasin**, is a naturally occurring 28-amino-acid thymic polypeptide. It acts as a potent biological response modifier and immunomodulator, restoring T-cell maturation, enhancing innate and adaptive immunity.
1. Chemical Structure and Biochemistry
Thymosin Alpha-1 is cleaved endogenously from its precursor protein, prothymosin alpha.
- Peptide Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn
- Structural Modification: The synthetic pharmaceutical form is N-terminally acetylated and highly acidic, demonstrating strong aqueous solubility and stability in physiological buffers.
2. Mechanism of Action
Thymosin Alpha-1 acts as a pleiotropic immune regulator rather than a non-specific stimulant, capable of both upregulating weak immune responses and dampening hyperinflammation.
- Toll-Like Receptor (TLR) Signaling: Activates TLR2 and TLR9 on dendritic cells and macrophages, stimulating antigen presentation and upregulating Major Histocompatibility Complex (MHC) Class I expression.
- T-Cell & NK Cell Maturation: Promotes the differentiation of thymocytes into mature $\text{CD4}^{+}$ (helper) and $\text{CD8}^{+}$ (cytotoxic) T-lymphocytes, enhances Natural Killer (NK) cell activity, and stimulates Th1 cytokines (IL-2, IFN-$\gamma$) while balancing regulatory T-cells (Tregs) to prevent cytokine storms.
3. Research and Applications
Marketed globally as Zadaxin, Thymosin Alpha-1 is approved in over 35 countries (though not FDA-approved for general clinical use in the United States, where it holds orphan drug designations).
- Infectious Diseases: Clinically used and researched as an adjunct therapy for chronic Hepatitis B and C, severe sepsis, and immune-compromised viral infections.
- Oncology & Vaccine Adjuvant: Studied alongside chemotherapy and checkpoint inhibitors to mitigate immunosuppression, as well as to boost antibody responses to vaccines in elderly or immunocompromised populations.
Tags:
Thymosin-Alpha-1
Thymalfasin
Zadaxin
T-alpha-1
immunomodulator
thymic-peptide
T-cell-maturation
TLR2
TLR9
NK-cells
Hepatitis-B